RIPK1 and melanoma: This mechanism involves the suppression of the K63-linked polyubiquitin chains of RIPK1 (receptor-interacting protein kinase 1) by CYLD, thereby promoting its degradation, a mechanism that does not appear to be exclusive to melanoma [86].